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Nociceptors in peripheral ganglia display a remarkable functional heterogeneity. They can be divided into the following two major classes:
peptidergicandnonpeptidergicneurons.AlthoughRUNX1hasbeenshowntoplayapivotal role in thespecificationofnonpeptidergicneurons,
the mechanisms driving peptidergic differentiation remain elusive. Here, we show that hepatocyte growth factor (HGF)-Met signaling acts
synergistically with nerve growth factor-tyrosine kinase receptor A to promote peptidergic identity in a subset of prospective nociceptors.We
provide invivoevidencethatapopulationofpeptidergicneurons,derivedfromtheRUNX1lineage,requireMetactivity for theproperextinction
ofRunx1andoptimal activationofCGRP (calcitoningene-relatedpeptide).Moreover,we showthatRUNX1 in turn repressesMet expression in
nonpeptidergic neurons, revealing a bidirectional cross talk betweenMet and RUNX1. Together, our novel findings support amodel in which
peptidergic versus nonpeptidergic specification depends on a balance betweenHGF-Met signaling andRunx1 extinction/maintenance.
Introduction
Sensory neurons of the dorsal root ganglia (DRG) detect and trans-
duce somatosensory stimuli from the periphery and convey this in-
formation to the spinal cord. Most sensory neurons arise from
neural crest cells that migrate ventrally to form the DRG (White et
al., 1996; Raible and Ungos, 2006; Marmige`re and Ernfors, 2007).
Neuronal precursors in the ganglion undergo the first specification
process [embryonic day (E)10.5–E13.5 in themouse] that gives rise
to the three principal neuronal subtypes: nociceptive-thermo-
ceptive, mechanoceptive, and proprioceptive neurons. Each neuro-
nal population requires a specific neurotrophic support for proper
survival and expresses distinct neurotrophin receptors of the Trk
family (Lewin, 1996; Patapoutian and Reichardt, 2001). After this
earlydiversification event, a secondmaturation step further expands
the heterogeneity within each population. In nociceptive neurons,
this phase is characterized by the progressive segregation of tyrosine
kinase receptor A (TrkA) neurons into two subpopulations: pepti-
dergicneurons that retain theexpressionofTrkAreceptorandsignal
through nerve growth factor (NGF); and nonpeptidergic neurons
that extinguish TrkA and respond to glial cell-derived neurotrophic
factor-Ret signaling (Molliver et al., 1997; Iba´n˜ez and Ernfors, 2007;
Luo et al., 2007;Woolf andMa, 2007).
Recent work has given new insights into themolecular control
of late nociceptive maturation. A number of studies provided
genetic evidence that persistent expression of the transcription
factor RUNX1 is the key event for prospective nociceptors to
undergo nonpeptidergic differentiation (Chen et al., 2006;
Kramer et al., 2006b;Marmige`re et al., 2006;Woolf andMa, 2007;
Yoshikawa et al., 2007). However, it is still unclear whether the
peptidergic phenotype is the default differentiation pathway in
prospective nociceptive neurons devoid of RUNX1 or, rather, an
active process of cell fate choice. Given that the population of
RUNX1 prospective nociceptors (10% of the total popula-
tion) cannot account for the number of peptidergic neurons ob-
served in the adult DRG (25% of the total population) (Chen et
al., 2006), it has been proposed that a subset of RUNX1 progeni-
tors actively turnoffRunx1 expressionandacquirepeptidergic iden-
tity (Woolf andMa, 2007). In agreement with this hypothesis, it has
been shown that expression of some ion channels of the transient
receptor potential (TRP) family, normally expressed in adult pepti-
dergic neurons, is lost in the absence of Runx1. These observations
strongly suggest that peptidergic neurons (or at least, a subset of
them) derive from Runx1-expressing precursors.
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How isRunx1 expression controlled during nociceptive segrega-
tion? Recent work demonstrated thatNGF signaling is necessary for
the maintenance of Runx1 in nonpeptidergic nociceptive neurons
(Luoetal., 2007). Sincebothpeptidergic andnonpeptidergicneurons
requireNGFforproperdevelopment(Smeyneetal.,1994), theseobser-
vations strongly suggest that additional factor(s), in concert withNGF,
ensure the extinction of Runx1 in a subset of prospective peptidergic
neurons. However, the molecular identity of such factor(s) has re-
mained elusive.
Here, we provide the first in vivo evidence that a subset of
peptidergic nociceptive neurons do derive from the RUNX1 lin-
eage.We also identify a novel regulatorymechanism involving an
active repressive loop betweenMet and RUNX1 that specifies the
molecular identity of this subpopulation of nociceptive neurons.
We show that, in conditional Met knock-out mice, a subset of
prospective peptidergic neurons is no longer able to extinguish
Runx1, leading to incomplete segregation of RUNX1 fromTrkA
neurons. The consequence of this RUNX1 persistence is the loss of
several peptidergic markers, including CGRP, TRPV1, and TRPA1,
as well as the expansion of the intermediate population of neurons
expressing both TrkA and Ret. Conversely, disruption of Runx1 ex-
pression in the peripheral nervous system resulted in a massive de-
regulation of Met and impaired maturation of nonpeptidergic
neurons, arguing that persistent expression of RUNX1 is necessary
to repress Met and instruct nonpeptidergic differentiation. Collec-
tively, our findings indicate thatMet/RUNX1cross talk is akey event
in the molecular logic of primary sensory neuronal diversification,
thereby extending our understanding of nociceptive diversification.
Materials andMethods
Animals. We first introduced the Metd allele [in which the mutation of
two key tyrosine residues renders Met receptor functionally inactive
(Ponzetto et al., 1994)] into a mouse strain expressing Cre recombinase
under nestin promoter (Nestin-Cre mice) (Isaka et al., 1999; Kramer et
al., 2006b; Zhong et al., 2007) to obtainMetd/;Nes-Cre animals. These
animals were then crossed to previously described Metflx/flx mice [in
which two loxP sites flank Met exon 16 (Huh et al., 2004)], kindly pro-
vided by Dr. Snorri S. Thorgeirsson (National Cancer Institute, National
Institutes ofHealth, Bethesda,MD).Mice obtained from that breedingwere
tail genotyped using Cre-, Metd-, and Metflx-specific primers. Conditional
Met knock-out animals (Metflx/d;Nes-Cre, calledNes-Met) and control lit-
termates (Metflx/d;Nes-Cre, called control)were used for all analysis.Runx1
mutant animals were a generous gift from Dr. Ma (Dana Farber Cancer
Institute, Boston, MA) and have been previously characterized (Chen et al.,
2006). Runx1Cre mice were provided by Dr. I.M. Samokhvalov (RIKEN
Kobe,Kobe, Japan) andhavebeendescribedpreviously (Samokhvalov et al.,
2007). Runx1-LacZ animals were a generous gift from Dr. Nancy A. Speck
(University of Pennsylvania, Philadelphia, PA) and have been previously
described (North et al., 1999). Animals were maintained under standard
housing conditions (25°C, 40% humidity, 12 h light cycles, and free access to
food andwater). Special effortwasmade tominimize the number aswell as the
stress and suffering of mice used in this study. All
protocols are in agreement with European Union
recommendations for animal experimentation.
In situ hybridization and immunofluores-
cence. In situ hybridization and immunofluo-
rescence were performed following standard
protocols (Moqrich et al., 2004). To obtain
adult tissues, animals were deeply anesthetized
with amix of ketamine/xylazine and then tran-
scardially perfused with an ice-cold solution of
paraformaldehyde 4% in PBS (PAF). After dis-
section, they were postfixed for at least 24 h in
the same fixative. Embryos were collected in
ice-cold PBS, gently washed, and fixed for 48 h
in 4% PAF. For skin immunofluorescence,
trunk skin was excised from anesthetized ani-
mals and fixed directly in 15% (v/v) acid picric–2% formaldehyde for
16 h. Tissues were then transferred into a 30% (w/v) sucrose solution for
cryoprotection before being frozen and stored at 80°C. Samples were
sectioned using a standard cryostat (Leica).
RNA probes were synthesized using gene-specific PCR primers and
cDNA templates fromembryonic or adultmouseDRG.Double-fluorescent
in situhybridizationwas performedusing a combinationof digoxigenin and
fluorescein/biotin-labeled probes. Probes were hybridized overnight at
55°C, and the slides incubated with the horseradish peroxidase anti-digoxi-
genin/fluorescein/biotin antibody (Roche). Final detectionwas achieved us-
ing fluorescein/cy3/cy5 TSA plus kit (PerkinElmer). For double-fluorescent
in situ experiments, the first antibodywas inactivatedusingH2O2 treatment.
For immunofluorescence, primary antibodies were diluted in PBS-
10% donkey serum (Sigma)-3% bovine albumin (Sigma)-0.4% Triton
X-100 and incubated overnight at 4°C. Corresponding donkey anti-
rabbit or anti-goat Alexa 488, 555, or 647 (Invitrogen) were used for
secondary detection. Primary antibodies used in this study are as follows:
rabbit anti-TrkA 1:1000 (generous gift fromDr. L. Reichardt, University
of California, San Francisco, CA), rabbit anti-Runx1 1:4000 (generous
gift from Dr. T. Jessell, New York University School of Medicine, New
York, NY), rabbit anti-activated caspase-3 1:2000 (Cell Signaling Tech-
nology), goat anti-TrkC 1:500 (R&D Systems), goat anti-Ret 1:500 (R&D
Systems), rabbit anti-calcitonin gene-related peptide (CGRP) 1:1000 (Milli-
pore Bioscience Research Reagents), chicken anti-green fluorescent protein
(GFP) 1:1000 (Aves Labs), and goat anti-parvalbumin 1:2000 (Swant).
DRG cultures, transfection, and growth factors.DRG cultures were pre-
pared following standard protocols. Briefly, DRG from embryonic day
(E) 14.5 embryos were collected in cold DMEM. After trypsinization (10
min at 37°C), tissue was triturated using a fire-polished Pasteur pipette.
Cells were then rinsed in Roswell Park Memorial Institute (RPMI) me-
dium and counted before transfection.
DRG neurons were transfected using Amaxa Nucleofection. For each
transfection reaction, 5  105 cells were used. To limit cell death after
transfection, a recovery step (15 min in RPMI medium) was performed.
Cells were then plated onto 35mmdishes coatedwith poly-L-lysine (Sigma)
containing pre-equilibrated culture medium. Cells were grown in Neuro-
basal (Invitrogen) supplemented with 2% B27 (Invitrogen) and 100 M
sodiumpyruvate. Culturemediumwas replaced 2 and 24h after transfection.
Plasmid containing the human Met was provided by Professor C.
Ponzetto (University of Turin, Turin, Italy). For nucleofection, 1 g of
plasmid DNA/reaction was used.
Exogenous growth factors were added to the culture medium imme-
diately after transfection. Recombinant NGF was purchased from
Alomone Labs, and hepatocyte growth factor (HGF) fromR&DSystems.
Reverse transcription-PCR. RNA was extracted (embryonic or adult
DRG, PC12, and DRG cultures) using TriZol reagent (Invitrogen) ac-
cording to manufacturer’s protocol. Total RNA (1 g) was converted to
cDNA using oligodT15 as primer and ImPromII reverse transcriptase
(Promega). Reverse transcription was performed for 1 h at 42°C.
For PCR, GoTaq polymerase (Promega) and a standard thermal cycler
(AppliedBiosystems)wereused.Real-timePCRwasperformed inan iCycler
system (Bio-Rad). PCRs were performed in triplicate using SYBRGreen ER
reagent system(Invitrogen). EachSYBRGreen reaction (25l total volume)
Figure 1. A population of CGRP peptidergic neurons arises from RUNX1 precursors. Fate-mapping analysis of RUNX1
lineage using tamoxifen-inducible Runx1Cre. Representative examples of CGRP and YFP immunofluorescence in newborn DRG of
Runx1Cre Rosa26eYFP injected with 4-OHT at E12.5. These lineage experiments clearly demonstrated that a number of CGRP
peptidergic neurons (arrowheads) derive from cells expressing RUNX1 at early developmental stages. Scale bars, 20m.
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contained 1 l of cDNA as template and 0.3 M each primer. Controls
without template DNA (water and reverse transcription reaction) were al-
ways negative. The reactions were incubated at 95°C for 10 min to activate
theHotStarTaqpolymerasefollowedby40cyclesat95°Cfor15s(denaturation)
and at 60°C for 1min (annealing and extension). -Actin was used as internal
control.TheoligonucleotideprimersusedforPCRwereshowninsupplemental
Table 1 (available atwww.jneurosci.org as supplementalmaterial).
Because SYBRGreen indiscriminately binds to double-strandedDNA,
other products in the PCR such as primer dimers may be detected along
with the target gene. To verify that the SYBRGreen dye detected only one
PCR product, the samples were subjected to the heat dissociation proto-
col after the final cycle of the PCR.
Cell counts and statistical analysis. For adult tissues, we adopted a strat-
egy that has been previously validated for DRG cell counts (Chen et al.,
2006). Briefly, serial sections of thoracic DRG were distributed on six
slides, which were subjected to different markers including the pan-
neuronal marker SCG10. This approach allowed us to refer all countings
to the total number of neurons (SCG10). For each genotype, two to four
DRGwere counted in at least three independent animals. For embryonic
tissues, after counting the total number of neurons expressing a certain
marker, we related that figure to the number of sections. All cell counts
were conducted by an individual who was blind to the experimental
condition of the animals. Statistical significance was set to p 0.05 and
assessed using one-way ANOVA followed by unpaired t test (all other
experiments).
Cell lines and transfection. PC12 cells were cultured in DMEM supple-
mented with 10% fetal calf serum (FCS) and 5% horse serum. The day
before transfection cells were trypsinized and cells plated onto 5 cm
dishes [for quantitative reverse transcription (RT)-PCR; 5 105 cells] or
six well plates (for luciferase assays; 2  105 cells) coated with poly-
ornithine. Transfection was performed using Lipofectamine reagent and
Opti-MEMmedium (Invitrogen) following the manufacturer’s instruc-
tions. After 6 h, transfection complexes were removed and cells cultured
overnight in DMEM with no serum.
To test Met overexpression, HEK cells were cultured in DMEM-10%
FCS. The day before transfection, they were plated onto 10 cm dishes.
This cell line was transfected using Promofectin reagent (PromoKine)
following the manufacturer’s instructions.
For treatment with exogenous growth factors, cells were starved over-
night in serum-free medium and the next day recombinant NGF
(Alomone Labs), HGF (R&D Systems), EGF (R&D Systems), and FGF8
(R&D Systems) were added to the medium.
Western blot.HEK cells were first homogenized in ice-cold disruption
buffer (20 mM Tris-HCl, pH 7.4, 10 mM NaCl, 10 mM KCl, 3 mM
Figure2. Met is expressed in a subset of adult DRGneurons.a, Pictures of adult DRG illustratingdouble labeling ofMet togetherwith differentmarkers of specific neuronal populations. As shown,
most Met neurons are TrkA/CGRP peptidergic neurons. It is also expressed in some TrkC neurons (arrowheads). In contrast, Met is largely excluded from Ret/RUNX1 population of
nociceptive neurons and TrkBmechanoceptive neurons. Immunofluorescence for CGRP, TrkA, TrkC, Ret, and RUNX1. In situ hybridization forMet and TrkB. b, Proportions ofMet cells expressing
different markers (data obtained from three different animals) and size distribution of Met neurons. c, Pictures illustrating coexpression of Met and RUNX1 at E16 in Runx1 LacZ reporter embryos.
Immunoflurescence for LacZ. In situ hybridization forMet. Scale bars: a, 50m; b, 30m.
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MgCl2, 0.5% NP-40) containing a protease inhibitor mix. After son-
ication, samples were centrifuged for 10 min at 10,000 g at 4°C. The
supernatant was removed and stored at 80°C. Fifty micrograms of
protein was electrophoresed and then transferred to a nitrocellulose
membrane in 25 mM Tris, 192 mM glycine, and 20% ethanol. After
blocking (for 1 h at room temperature in Tris buffer containing 5%
nonfat dried milk and 0.05% Tween-20), blots were incubated in
primary mouse monoclonal antibody anti--tubulin 1/10,000
(Sigma) or rabbit polyclonal anti-human Met 1/500 (Santa Cruz Bio-
technology) overnight at 4°C. Membranes were rinsed three times,
incubated with the appropriate horseradish peroxidase-linked sec-
ondary antibody at 1/5000 (Jackson ImmunoResearch Laboratories)
for 1 h at room temperature and developed using ECL reagents
(PerkinElmer).
Results
A subpopulation of peptidergic neurons arise from the
Runx1 lineage
Previous studieshaveproposed thatRunx1downregulation is essen-
tial for a subpopulation of prospective nociceptors to undergo pep-
tidergic differentiation (Chen et al., 2006; Woolf and Ma, 2007).
Figure3. Met controlsRunx1extinction in vivo.a, Increasednumberof RUNX1neurons inNes-Metmutant animals. Pictures of RUNX1 immunofluorescence showamoderate increaseof RUNX1
neurons in Nes-Metmice. Quantitative analysis revealed a significant difference in these animals compared with control (*p 0.05; control, n 3; Nes-Met, n 3). b, Persistent expression of
RUNX1 inTrkAneurons inadultNes-Metmice. TrkA in situhybridization followedby immunofluorescence forRUNX1 revealed thatRUNX1 is completely excluded frompeptidergic neurons in control
animals (top). In contrast, a number of TrkA neurons maintains RUNX1 expression in adult Nes-Metmice (bottom) suggesting that Met is necessary for proper Runx1 extinction. Immunofluores-
cence for RUNX1. In situ hybridization for TrkA. Scale bars, 20m.
Figure4. RUNX1repressesMetexpression in vivo.Met isderepressed inRunx1/DRGneurons.Representativepictures illustrating the increaseofMetexpression inDRGneurons in theabsenceofRUNX1.
QuantitativeanalysisdemonstratedthatMet increase inRunx1/micewasparallel totheexpansionofCGRPpopulation. Interestingly, theproportionofCGRPMetneuronswasnotaffected(**p0.001,
control,n 3;Runx1/,n 3). Immunofluorescence for CGRP. In situhybridization forMet. Scale bar, 50m.
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However, experimental evidence showing that peptidergicCGRP/
TrkA neurons derive from the initial population of nociceptive
precursors coexpressing RUNX1 andTrkA is still lacking. To exam-
ine this possibility, we performed a fate-mapping analysis using a
recently developed tamoxifen-inducible Runx1-Cre knock-in
mouse strain (Runx1Cre) (Samokhvalov et al., 2007) crossed with
reporter mice (Rosa26-loxP-STOP-loxP-eYFP) (Srinivas et al.,
2001). To induce recombination, pregnant females received a single
injection of 4-hydroxytamoxifen at three developmental time
points: E11.5, E12.5, or E13.5. Using this system, and knowing that
88% of TrkA neurons coexpress Runx1 at E14.5 (Chen et al.,
2006), we first evaluated the efficiency of recombination by moni-
toring the proportion of DRG neurons coexpressing TrkA and en-
hanced yellow fluorescent protein (eYFP) at birth. We found that
pregnantmothers injected atE12.5 yielded thehighest proportionof
recombination inTrkAneurons comparedwith the twoother time
points (1.610.19%atE11.5,n2; 16.251.93%atE12.5,n5;
and 10.2  2.03 at E13.5 n  4). More importantly, we found a
moderately high proportion of CGRP neurons coexpressing eYFP
(10.3 1.9%; n 5) (Fig. 1). Taking into account the recombina-
tion efficiency, the percentage of CGRP neurons coexpressing
eYFP rose to 50.0 6.7%. These data provide the first in vivo evi-
dence showing that a subset of CGRP neurons (about one half)
derives from TrkA/RUNX1 progenitors (Fig. 1).
Met is expressed in a subset of DRG neurons
Lineage-mapping experiments indicate that a subset of peptider-
gic neurons extinguish Runx1 during development. In the search
for factors that could participate in Runx1 extinction, the HGF–
Met system was a particularly interesting candidate. Previous
studies have reported the presence of Met in DRG (Maina et al.,
1997; Funakoshi and Nakamura, 2001). More importantly, HGF
has been shown to act synergistically with NGF both in DRG and
superior cervical ganglia (SCG) neurons (Maina et al., 1997).
The expression pattern of Met in the somatosensory system has
not hitherto been examined in detail. Using in situhybridization,we
found in adult thoracicDRG thatMet is present in19.4 2.6%of
allDRGneurons.We then sought todeterminewhetherMet expres-
sion was restricted to precise neuronal populations. We observed
that 73.5  3.8% of Met neurons coexpress TrkA, indicating that
Met neurons mainly encompass peptidergic nociceptors (Fig.
2a,b). In support of this hypothesis, we found an extensive overlap
betweenMet and the neuropeptide CGRP. Indeed,80% ofMet
neurons coexpress CGRP and, conversely, 55.5 3.1% of the total
number of CGRP neurons coexpressMet (Fig. 2a,b).
We have also observed that Met is expressed in relatively few
Ret neurons (4.6 1.2% corresponding to 6.2 4.2% ofMet
neurons). Several lines of evidence suggest thatMet/Ret neu-
rons are not nociceptive but proprioceptive neurons. First, they
are large-diameter neurons and represent5% of the total num-
ber of Ret-expressing neurons. Second, a significant proportion
ofMet neurons are positive for proprioceptive markers such as
parvalbumin (PV) (18.1  5.3%) or TrkC (4.8  0.2%) (Fig.
2a,b). Third, andmore importantly, it seems thatMet and Runx1
have mutually exclusive expression patterns and are never ex-
pressed in the same neurons in the adult DRG (Fig. 2a). Finally,
we showed that most, if not all, TrkB putative mechanoceptive
neurons are devoid ofMet (1.2 0.9%).
We next examined the temporal expression pattern ofMet in
DRG. At E14.5, Met is mainly expressed in large neurons (sup-
plemental Fig. 1a, available at www.jneurosci.org as supplemen-
tal material) and is coexpressed with PV (supplemental Fig. 1b,
available at www.jneurosci.org as supplemental material). As de-
velopment proceeds, Met expression expands and starts to be
detected in a subset of small-diameter CGRP neurons (supple-
mental Fig. 1c,d, available at www.jneurosci.org as supplemental
material).
We hypothesized that progressive expression of Met in a sub-
set of CGRP neurons might be the key event for Runx1 extinc-
tion in vivo. An absolute prerequisite to validate this hypothesis is
Figure 5. Conditional Nes-Met mutants do not show defects in the number of neurons
or early specification of nociceptive and proprioceptive neurons. a, Quantification of DRG
neurons using the pan-neuronal marker SCG10 revealed no differences between Nes-Met
and their control littermates (control, n 3; Nes-Met, n 3). b, Representative pictures
illustrating the distribution of TrkA, TrkC, and PV-expressing neurons in control and Nes-
Met DRG. Immunofluorescence for TrkA and TrkC. In situ hybridization for PV. c, Quantita-
tive analysis of the numbers of DRG neurons positive for TrkA, TrkC, and PV showed no
significant differences in Nes-Met mutants compared with control mice (control, n 4;
Nes-Met, n 4). Scale bars, 50m.
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that both factors need to be coexpressed at a certain point during
nociceptor development. To confirm the existence of this tran-
sient population, we took advantage of a previously described
Runx1 reporter mouse strain (Runx1LacZ) (North et al., 1999).
Consistent with our hypothesis, a number of RUNX1 Met
double-labeled neurons could be easily identified at E16.5 (Fig.
2c). These results suggest that the expression profile of Met is
compatible with a potential role in Runx1 extinction.
Generation of Met conditional knock-out mice
The specific expression pattern ofMet in distinct DRG neuronal
subpopulations prompted us to investigate the role ofMet during
the acquisition of primary sensory neuron identity. Embryos ho-
mozygous for the null allele ofMet or for the signaling-deadMetd
allele die between E13.5 and E16.5 (Bladt et al., 1995;Maina et al.,
1997). Moreover, an increased apoptotic rate had beenmeasured
in theDRGofMetd/d embryos at E11.5-E12.5 (Maina et al., 1997).
To circumvent potential survival defects and to uncover the in
vivo role of Met during late maturation of DRG neurons, we
generated a neuronal-restricted Met loss-of-function mouse
model. Mice with a loxP-based conditional Met allele (Maina et
al., 1998; Huh et al., 2004) were crossed with aNestin-Cremouse
strain (Kramer et al., 2006a; Zhong et al., 2007).Met conditional
knock-out mice (Metd/flx; Nestin-Cre, hereafter, referred to as
Nes-Met) are viable and fertile, grow at a normal rate, and show
no obvious defects when compared with their Metd/flx; Nestin-
Cre littermates (hereafter, control).
To verify the efficiency of our conditional loss-of-function
approach, Met transcripts levels in control and Nes-Met DRG
were assessed at different developmental stages using quantitative
RT-PCR (supplemental Fig. 2a, available at www.jneurosci.org as
supplemental material). We observed no significant difference at
E12.5. In contrast, the amount ofMetmRNA declined markedly
at E15.5 and reached very low levels in the adult Nes-Met DRG.
Consistent with the absence of effect onMet expression at E12.5,
we found no significant difference in the
number of activated caspase 3-positive
neurons between Nes-Met and control
embryos (supplemental Fig. 2b,c, avail-
able at www.jneurosci.org as supplemen-
tal material). These results contrast with
the significant increase in apoptosis seen
in Met knock-out mice (Maina et al.,
1997). Our data indicate that Cre expres-
sion under the control ofNestin promoter
mediates effective loxP recombination in
neurons well after the previously de-
scribed period of cell death in the DRG
(E10.5–E12.5) (Snider, 1994; White et al.,
1996).
We next sought to investigate whether
the efficiency of Nes-Cre recombination
varied in a different subpopulation of
DRG neurons. For that purpose, we
crossed Nes-Cre animals with a reporter
strain carrying aRosa26loxP-Stop-loxP-LacZ al-
lele. Analysis of postnatal DRG (postnatal
day 7) revealed that Cre-mediated recom-
bination took place in the large majority
of CGRP nociceptive neurons (80%,
n  3) (supplemental Fig. 2c, available at
www.jneurosci.org as supplemental ma-
terial). Altogether, our results showed that
targeted inactivation of Met using the Nestin promoter to mediate
cre recombination represents an appropriate strategy to investigate
the role of HGF/Met signaling in late nociceptive neuronal
diversification.
Met signaling controls Runx1 expression both in vivo and
in vitro
It has been shown that RUNX1 negatively regulates CGRP
expression in vivo (Chen et al., 2006; Kramer et al., 2006b; Mar-
mige`re et al., 2006) and that Runx1 expression is maintained
through NGF signaling (Luo et al., 2007). One attractive hypoth-
esis integrating all these data is that prospective nociceptors that
respond only to NGF/TrkA signaling will maintain RUNX1, ac-
tivate Ret, and adopt a nonpeptidergic fate, whereas those that
respond to a signal emanating from the synergistic action of NGF
and HGF would turn off Runx1, activate CGRP, and adopt a
Figure 6. Disruption of peptidergic markers in Nes-Metmice. a, Expression of the peptidergic markers CGRP, Trpv1, and Trpa1
in control and Nes-Met DRG. Immunofluorescence for CGRP, IB4, and TrkC. In situ hybridization for Trpv1 and Trpa1. b, Neuronal
counts revealed thatMet deletion led to a significant reduction in the number of DRG neurons expressing CGRP, Trpv1, and Trpa1
(control, n 3; Nes-Met, n 3; **p 0.01, *p 0.05). Scale bar, 50m.
Table 1. Quantitative analysis of molecular markers in wild-type and Nes-Metmice
Markers WT (%) (n 3) Nes-Met (%) (n 3) p
Ret 48.62 1.64 61.46 4.61 0.02
Runx1 34.29 1.38 48.06 4.77 0.019
Mrgpra1 2.2 0.65 2.01 0.32 n.s.
Mrgpra3 3.01 1.23 2.88 1.12 n.s.
Mrgprd 21.61 1.65 20.27 2.83 n.s.
IB4 26.69 0.7 25.71 9.13 n.s.
Trpm8 2.68 0.19 2.46 0.81 n.s.
TrkC 7.76 0.83 7.81 2 n.s.
PV 4.86 0.31 4.67 0.22 n.s.
TrkA 25.56 3.19 27.32 4.4 n.s.
CGRP 21.18 3.13 11.06 2.32 0.01
Trpv1 high 6.54 0.98 3.77 0.38 0.028
Trpv1 total 29.94 4.98 29.65 3.55 n.s.
Trpa1 high 4.69 0.37 2.16 0.41 0.001
Trpa1 total 40.43 6.38 31.63 3.03 n.s.
SP high 8.69 0.78 14.06 2.17 0.038
SP total 18.62 4.16 22.04 4.44 n.s.
WT, Wild-type mice.
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peptidergic fate. To explore this possibility, DRG cultures were
transfected with a GFP-reporter vector alone or together with a
plasmid driving human Met overexpression (supplemental Fig.
3, available at www.jneurosci.org as supplemental material). Im-
mediately after transfection, neurons were treated for 24 h with
no growth factors, NGF (20 ng/ml), HGF (50 ng/ml), or a com-
bination of NGF (20 ng/ml) and HGF (50 ng/ml), and the levels
of Runx1 were assessed by quantitative RT-PCR (supplemental
Fig. 3, available at www.jneurosci.org as supplemental material).
We found that although HGF alone did not modify Runx1 tran-
scription, the combination of HGF and NGF led to a significant
reduction of Runx1 transcripts compared with NGF-treated cul-
tures ( p  0.05) (supplemental Fig. 3, available at www.
jneurosci.org as supplemental material). Overexpressing human
Met in DRG neurons resulted in a more pronounced decrease of
Runx1 levels in response toHGF ( p 0.05) (supplemental Fig. 3,
available at www.jneurosci.org as supplemental material). Simi-
lar results were obtained in PC12 cells (data not shown). To-
gether, these in vitro studies indicated that activation of the
Met-signaling cascade interferes with TrkA-triggered Runx1
transcriptional regulation.
We next sought to examine whether repression of Runx1 by
Met signaling also occurs in vivo. For that purpose, we followed
Runx1 expression in Nes-Met mutants and control mice. We
found that, at E15.5 and E18.5, the number of RUNX1 neurons
was similar inNes-Met and control embryos (data not shown). In
contrast, there was a significant increase in RUNX1 in the adult
DRG (34.3 1.4% in control and 48.1 4.8% in Nes-Met; p
0.019) (Fig. 3a). These observations strongly argue for a repres-
sive effect of Met on Runx1 expression in vivo.
We hypothesized that ifMet is necessary forRunx1 extinction,
thenRUNX1might persist in adult peptidergic TrkAneurons in
the Nes-Met mice. As expected, TrkA and RUNX1 are largely
segregated in non-overlapping populations in control animals
(Fig. 3b). In contrast, a number of TrkA neurons coexpress
RUNX1 in Nest-Met animals, demonstrating that Runx1 extinc-
tion is impaired in the absence of Met. Altogether, these findings
demonstrate that, in vivo, Met activity is required for proper ex-
tinction of Runx1 in a subset of DRG sensory neurons.
RUNX1 suppressesMet expression in vivo and in vitro
We next sought to examine whether RUNX1 exerts a similar
repressive effect onMet to ensure the generation of nonpeptider-
gic neurons. To verify this bidirectional regulation of Met and
RUNX1, we examined Met expression in DRG of conditional
Runx1 knock-out mice (Runx1/) (Chen et al., 2006). We
found a dramatic expansion ofMet neurons in Runx1/DRG
(16.8  0.7% in control and 61.6  6.7% in Runx1/; p 
0.001) (Fig. 4), which correlates with the previously described
increase in the proportion of CGRP nociceptive neurons in
Runx1/ mice. These findings demonstrate that RUNX1 also
represses Met in vivo and further supports the role of Met in
regulating CGRP expression.Moreover, the proportion of CGRP
neurons expressingMetwas found to be significantly increased in
Runx1/ compared with controls (54.7 10.1% in control and
86.1 4.5% in Runx1/, p 0.01). Interestingly, the number
of CGRPMet neurons was not significantly altered (11.5 
4.6% in control and 8.4 2.7% in Runx1/, p 0.35) (Fig. 4),
suggesting that the subset of peptidergic neurons that does not
expressMet (representing about one half of the CGRP neurons
in control mice) is not regulated by RUNX1. Finally, PC12 cells
transfected with a plasmid driving human Runx1 expression ex-
hibited significantly lower levels ofMet transcript comparedwith
GFP-transfected or naive PC12 cells (data not shown). Alto-
gether, these findings demonstrate the impact of RUNX1 repres-
sor activity on Met expression and the importance of a proper
balance between RUNX1 andMet for the correct development of
nonpeptidergic nociceptive neurons.
Impaired maturation of a subset of peptidergic neurons in
Nes-Metmice
We next investigated the impact of Met loss of function on the
molecular diversification of DRG neurons. We found similar
DRG neuronal counts in adult Nes-Met and control mice (Fig.
5a), confirming that the trophic effect elicited by the HGF/Met
Figure 7. Phenotypic switch of nociceptive neurons in Nes-Metmice. a, Double staining of
TrkA/Ret andTrkA/SP showedan increase in thenumberofDRGneuronspositive forRet, SP, and
TrkA/Ret (arrowheads) in Nes-Metmice. Conversely, TrkA remained unchanged. Immunofluo-
rescence for TrkA and Ret. In situ hybridization for SP.b, Quantitative analysis of the percentage
of Ret and SP-expressingneurons (left) demonstrateda significant increase inNes-MetDRG. The
proportion of double-labeled TrkA/Ret neurons is also augmented (right) (control, n 4;
Nes-Met, n 5; p 0.05). c, Schematic representation of the observed defects of nociceptive
maturation inNes-Metmice. Briefly, a subset of prospective peptidergic CGRPneurons is lost (dot-
ted line) and switch their fate to becomeTrkA/Retneurons expressing SP. Scale bar, 50m.
12420 • J. Neurosci., September 15, 2010 • 30(37):12414–12423 Gascon et al. •Met and Nociceptor Diversification
system is only confined to early DRG neurons developmental
stages (Maina et al., 1997). We then assessed the different sub-
populations of DRG neurons and found that expression of PV
and TrkC remained unaffected (Table 1, Fig. 5b,c). Similarly,
markers of nonpeptidergic nociceptive neurons such as IB4,Mrg-
pra1,Mrgpra3, orMrgprd (Table 1) were not altered in Nes-Met
animals. These results indicate that Met inactivation does not
affect either proprioceptive or nonpeptidergic nociceptive neu-
rons differentiation.
When we examined CGRP expression, on the other hand, we
found it to be markedly reduced in Nes-Metmutants (Fig. 6a,b).
In the adult thoracic DRG, CGRP is expressed in 21.2 3.1% of
neurons, whereas this percentage is reduced to 11.1  2.3% in
Nes-Met mice ( p  0.01). Accordingly, the dorsal horn of the
spinal cord and the trunk skin showed decreased immunoreac-
tivity to CGRP staining in Nes-Met mice, suggesting that less
central and peripheral projections express this neuropeptide
(supplemental Fig. 4a,b, available at www.jneurosci.org as sup-
plemental material). However, staining with IB4 and the pan-
neuronal marker PGP9.5 showed no differences between control
andNes-Met animals, suggesting that both central and peripheral
axonal pathfinding occurs normally when Met is lost at late de-
velopmental stages.
We also found that the expression of other proteins specific to
CGRP nociceptive neurons is perturbed in Nes-Met animals.
Previous studies have shown that TRPV1 is expressed in both
peptidergic andnonpeptidergic neurons (Price andFlores, 2007),
with peptidergic neurons being more responsive to capsaicin
than nonpeptidergic neurons (Dirajlal et al., 2003). When we
quantified the total number of trpv1 neurons, we found no
difference between control and Nes-Metmice (Table 1). Impor-
tantly, the percentage of neurons expressing high levels of trpv1
was significantly reduced in mutant mice (control 6.5  1%;
Nes-Met 3.8 0.6%; n 3; p 0.02) (Fig.
6a,b, Table 1). Similarly, the total number
of trpa1 neurons was found to be only
moderately decreased in Nes-Met mice
(Table 1), whereas the difference was sig-
nificant for neurons expressing high levels
of trpa1 (control, 4.7  0.4%; Nes-Met,
2.2  0.4%; n  4; p  0.001) (Fig. 6a,b,
Table 1). In agreement with these obser-
vations, we found that Ca2 transients in
response to capsaicin (1 M) or allyl-
isothiocyanate (1 M) had significantly
smaller amplitudes in DRG neurons from
Nes-Met compared with control mice
(data not shown). Interestingly, TrkA
neuronal counts were not perturbed in
the absence of Met (25.6  3.2% in con-
trol vs 27.3 4.4% inNes-Met). Together,
these results indicate that the late matura-
tion of peptidergic neurons is specifically
impaired in Nes-Metmice.
A subset of peptidergic neurons
switches fate in the absence of Met
Weexamined themolecular phenotype(s)
adopted by the subset of presumptive
TrkA/CGRP peptidergic neurons. Pre-
vious studies have shown that adult noci-
ceptive neurons can be divided into the
following three classes (Molliver et al.,
1997; Woolf and Ma, 2007): TrkA peptidergic neurons; Ret
nonpeptidergic neurons; and a poorly characterized subtype of
neurons expressing both TrkA and Ret receptors. Unexpectedly,
quantitative analyses showed that Nes-Met mutant animals dis-
played a significant increase in the proportion of Ret-expressing
neurons (48.6  1.6% in control and 61.5  4.6% in Nes-Met;
p  0.02) (Fig. 7). Given that the proportion of TrkA neurons
was unchanged in Nes-Metmice, we next investigated whether a
lack of Met signaling led to an expansion of the neuronal popu-
lation coexpressing TrkA andRet. Importantly, we found that the
number of TrkA/Ret neurons was doubled in Nes-Met mu-
tants compared with control mice (control, 9.1  0.7%, n  3;
Nes-Met, 18.4 3.7%, n 3). Moreover, when this proportion
of TrkA/Ret neurons was normalized to the total number of
TrkA or Ret neurons, only the TrkA ratio was significantly
increased ( p 0.05) (Fig. 4b). Thus, these results reveal a poten-
tial role of Met in nociceptive maturation before TrkA-Ret seg-
regation. In addition, they indicate that loss of Met signaling
drives a subset of peptidergic neurons from a TrkA/CGRP to a
TrkA/Retmolecular phenotype.
The population of TrkA/Ret neurons has not hitherto been
described in detail. We therefore performed a number of triple-
staining experiments to definemolecularly this neuronal subtype
and found the neuropeptide substance P (SP) to be of particular
interest. SP has been previously described as a marker of pepti-
dergic neurons (Marmige`re and Ernfors, 2007). Nonetheless, our
quantitative analysis demonstrated that 43.1  5.5% of TrkA/
Ret neurons also express SP. As would be expected, we found
that SP-expressing neurons were markedly increased in Nes-Met
mutants compared with controls (Fig. 7b, Table 1).
Themolecular switch from TrkA/CGRP to TrkA/Ret in
Nes-Metmice suggests thatCGRP expressionmay be regulated by
Met in a subset of peptidergic neurons. To test this hypothesis, we
Figure8. Proposedmodel for latematuration of nociceptive neurons. As described previously, prospective nociceptive neurons
are TrkA at E14.5. At this stage, most of these cells (88%) coexpresses Runx1 (right column), whereas only a minor population
remains TrkARunx1 (left column). Our findings suggest that this latter population give rise to a subset of CGRP nociceptive
neurons independently from Runx1 and Met. According to our hypothesis, Runx1 high expressors would give rise to Ret non-
peptidergic neurons. Finally, low levels of Runx1might allow initialMet expression and the apparition of a transitory population of
MetRunx1 cells. Due to mutually repressive activity, this population would segregate and become either MetCGRP or
TrkARet neurons. Boxes in the lower part of the scheme represent the final distribution of different subsets of nociceptive
neurons in the absence ofMet (left) or Runx1 (right).
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followed the temporal expression pattern of CGRP in control and
Nes-Metmice. At E15.5, a time point at whichMet is not yet fully
expressed in nociceptive neurons, we found no difference in the
number of CGRP neurons in Nes-Met compared with control
embryos (supplemental Fig. 5, available at www.jneurosci.org as
supplemental material). It is worth noting that at this same time
point, CGRP just begins to be expressed in a subset of nociceptive
neurons (Funakoshi et al., 2003; our unpublished observations).
In contrast, a small, albeit significant, reduction of CGRP-
expressing neurons was detected in Nes-Met embryos at E18.5
(supplemental Fig. 5, available at www.jneurosci.org as supple-
mental material). These findings perfectly correlate with the late
onset and confinement ofMet expression to a subset of CGRP
neurons and raise the possibility that HGF-Met signaling regu-
lates CGRP expression exclusively in these neurons.
Discussion
Here we report a novel mechanism for peptidergic specification
involving a cross talk between RUNX1 and HGF-Met signaling.
We provide compelling in vivo evidence that a cohort of nocicep-
tive neurons acquires a peptidergic identity by using HGF-Met
signaling in concert with NGF-TrkA to extinguish Runx1 and
activateCGRP expression. Conversely, we also demonstrated that
a second subset of peptidergic neurons mature independently of
HGF-Met and RUNX1. Finally, we observed that persistent expres-
sion of RUNX1 is required for properMet repression in prospective
nociceptors undergoing nonpeptidergic differentiation. These data
indicate that a balance between RUNX1 and Met is essential to de-
termine nonpeptidergic versus peptidergic neuronal fate.
While intensive work has unraveled the transcriptional pro-
gram driving nonpeptidergic maturation (Chen et al., 2006;
Marmige`re et al., 2006; Luo et al., 2007; Yoshikawa et al., 2007),
little is known about the generation of peptidergic nociceptors.
Our findings, obtained using four complementary mice models
(Nes-Met, Runx1/, Runx1Cre, and Runx1LacZ), indicate that
peptidergic nociceptive neurons have a dual origin. Fate-
mapping analysis usingRunx1Cremice (Samokhvalov et al., 2007)
provides strong in vivo evidence that a class of peptidergic neu-
rons derive from a RUNX1 lineage. Data obtained fromNes-Met
mice show that a subset of presumptive peptidergic nociceptors
loses CGRP expression in the absence of Met. More importantly,
a thorough examination of Runx1/ DRG demonstrates that a
fraction of peptidergic neurons (CGRP Met) remains unaf-
fected in the absence of RUNX1 (representing50% of CGRP
neurons in the wild type) arguing that half of the TrkACGRP
neurons might be generated independently from Met and Runx1
(i.e., from TrkARunx1Met precursors). Conversely, the other
half could bemodified in the absence ofMet or RUNX1, indicating
that it might arise from TrkARUNX1Met precursors. Finally,
use ofRunx1LacZ transgenicmice allowedus to confirm the existence
of a transient population of TrkARUNX1Met precursors,
lending further support to the emerging theory of the dual
origin of peptidergic neurons. Collectively, these data provide
an additional aspect that highlights the exquisite refinement of
nociceptive maturation.
Mechanisms controllingRunx1 expression are still poorly un-
derstood (Marmige`re and Ernfors, 2007; Woolf and Ma, 2007).
Pioneering work fromDavid Ginty’s group has begun to unravel
the molecular pathways responsible for RUNX1 maintenance in
nonpeptidergic neurons (Luo et al., 2007). This study provided
compelling evidence that NGF signaling is crucial for this pro-
cess. In agreementwith these results, we observed thatNGF treat-
ment seems to be required for Runx1 expression in PC12 cells
(data not shown). The findings reported here demonstrated not
only that Runx1 extinction is an active process necessary for pep-
tidergic specification but also demonstrated that Met signaling is
an essential player in these events. We showed that deletion of
Met in the DRG resulted in a significant increase of RUNX1
neurons and therefore in a deficient peptidergic maturation.
More importantly, we showed that RUNX1 is retained in TrkA
neurons (Fig. 3b) from adult Nes-Met animals, indicating that
Met is essential for proper extinction of Runx1. Additionally,
primary cultures of DRG neurons treated with NGF and HGF
exhibit lower levels of Runx1. Thus, our finding that HGF-Met
contributes to Runx1 extinction extends our understanding of
the molecular control of Runx1 expression.
Based on our in vivo and in vitro results, we propose the fol-
lowingmodel of late nociceptor specification (Fig. 8). Depending
on Runx1 expression, prospective nociceptive neurons can be
divided into the following two classes (Chen et al., 2006):
RUNX1 neurons and RUNX1 neurons. According to our in
vivo data, the first population of peptidergic nociceptors most
likely derives fromTrkARUNX1neurons (Fig. 8, left column).
The absence of RUNX1 repressor activity would allow NGF-
TrkA signaling to drive peptidergic differentiation as previously
shown (Lindsay and Harmar, 1989; Freeland et al., 2000). This
population probably accounts for the remaining CGRP neu-
rons in the Nes-Met mice, as well as for the population of
CGRPMet neurons that is not modified in Runx1/ mice.
Regarding neurons expressing RUNX1, several scenarios could
be envisaged. In the first one, the final phenotype of these neu-
rons might depend on RUNX1 levels. The large majority of these
neurons express high levels of RUNX1 and would repress Met
expression, becoming therefore nonpeptidergic neurons (Fig. 8,
right column). In contrast, a small proportion of these same neu-
rons will express RUNX1 at a level that is permissive for Met
expression (Fig. 8, middle column). Given the mutually repres-
sive activity of Met and RUNX1, nociceptors coexpressing these
two factors might be transient and rapidly segregate either into
Met peptidergic (ifMet signaling is strong enough to extinguish
Runx1 expression) or into TrkA/Ret neurons (if RUNX1 ac-
tivity is strong enough to repressMet expression). An alternative
hypothesis is that RUNX1might change its transcriptional activ-
ity during development; at early stages, itmight act as an activator
(e.g., positively controlling Trp channels, Ret, and Met expres-
sion), whereas, later on, it might switch to a repressive state (e.g.,
negatively controlling CGRP), as previously shown for Mrg re-
ceptors (Liu et al., 2008). Finally, one could imagine that addi-
tional factors might participate in this process. Thus, access to
HGF might limit Met activation to certain neurons and/or ex-
pression of distinct cofactors might differentially modulate
RUNX1 activity.
Why is Runx1 expression activated only in a subset of TrkA
neurons? Prior work has revealed that nociceptive neurons are
generated in three sequential waves (Ma et al., 1999; Maro et al.,
2004; Kramer et al., 2006b; Marmige`re and Ernfors, 2007). The
first arises from neural crest progenitor cells expressing the tran-
scription factor Neurogenin2 (Ngn2). The second one is depen-
dent on Ngn1 cells and gives rise to the majority of nociceptive
neurons. Finally, the third wave derives from boundary cap cells
known to be Krox20 (Maro et al., 2004). It is well established
that RUNX1 is restricted to Ngn1-derived neurons (Ma et al.,
1999; Kramer et al., 2006b). Therefore, one attractive hypothesis
is that nociceptive neurons arising from other sources (Ngn2
progenitors and/or boundary cap cells) might give rise to the
population of TrkA/RUNX1 neurons. Analysis of RUNX1 in
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previously described Ngn mutants (Ma et al., 1999) might pro-
vide new insights into this issue.
Is this developmental diversification of peptidergic neurons
functionally relevant? Electrophysiological recordings showed
that DRG neurons exhibiting strong responses to capsaicin and
cinnamaldehyde mainly belong to the peptidergic class of noci-
ceptive neurons (Dirajlal et al., 2003; Story et al., 2003). Interest-
ingly, absence of RUNX1 leads to the expansion of a peptidergic
population, accompanied by the selective loss of Trpa1 and high
levels of Trpv1 (Chen et al., 2006). These molecular findings
nicely correlate with the decreased behavioral responses to cold
stimulation and noxious heat in Runx1/ knock-out mice. Our
observation that high levels, but not intermediate levels, of
TRPV1/TRPA1 are also affected in an independentmousemodel
(Nes-Met) gives further support to this hypothesis.
Collectively, the data presented in this study indicate thatMet
signaling is crucial for at least two elements of peptidergic matu-
ration: the extinction of Runx1 and the activation of CGRP ex-
pression. In this context, the reciprocal repression described here
for Met and RUNX1, as well as their subsequent segregation,
provide an attractive mechanism for the late diversification of
nociceptive neurons.
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